Changes in gene expression induced by tienilic acid and sulfamethoxazole: Testing the danger hypothesis

Journal of Immunotoxicology

Volumn 4, Issue 4, 2007, Pages 253-266

  Pacitto, Stephanie R ^a   Uetrecht, Jack P ^a   Boutros, Paul C ^b   Popovic, Marija ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Text Mining Services   (Switzerland)

Author keywords

Biomarkers; Cell stress; Gene expression; Idiosyncratic drug reactions; Sulfamethoxazole; Tienilic acid

Indexed keywords

ANTIBODY; AROMATIC AMINE; CASPASE 12; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; HAPTEN; INHIBIN; INHIBIN B; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; MESSENGER RNA; OXIDOREDUCTASE; SERINE DEHYDRATASE; SPECTRIN; SULFAMETHOXAZOLE; TIENILIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRESS; CONTROLLED STUDY; ELECTROPHILIC STRESS; ENZYME BINDING; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; INFLAMMATION; LIVER REGENERATION; LIVER TOXICITY; MALE; METABOLITE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRUCTURE ANALYSIS;

MUS; RATTUS;

EID: 36749029361     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910701680020     Document Type: Article

References (49)

1. Arand, M., Cronin, A., Adamska, M., and Oesch, F. 2005. Epoxide hydrolases: Structure, function, mechanism, and assay. Meth. Enzymol. 400:569-588.
2. Awad, M. M., Sanders, J. A., and Gruppuso, P. A.. 2000. A potential role for p15(Ink4b) and p57(Kip2) in liver development. FEBS Lett. 483:160-164.
3. 2+-dependent cell adhesion molecule expressed in liver and intestine. J. Cell Biol. 125:1353-1369.
4. Bezerra, J. A., Laney, D. W., Jr., and Degen, S. J. 1994. Increased expression of mRNA for hepatocyte growth factor-like protein during liver regeneration and inflammation. Biochem. Biophys. Res. Commun. 203:666-673.
5. Boulton, R., Woodman, A., Calnan, D., Selden, C., Tam, F., and Hodgson, H. 1997. Non-parenchymal cells from regenerating rat liver generate interleukin-1α and -1β: A mechanism of negative regulation of hepatocyte proliferation. Hepatology 26:49-58.
6. 1-induced genotoxicity: Mechanisms in rat and human cells. Food Chem. Toxicol. 39:549-556.
7. Chang, Q., Harter, T. M., Rikimaru, L. T., and Petrash, J. M. 2003. Aldo-keto reductases as modulators of stress response. Chem. Biol. Interact. 143-144:325-332.
8. Cribb, A. E., and S. P. Spielberg. 1990. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. Drug Metab. Dispos. 18:784-787.
9. Cribb, A. E., Nuss, C. E., Alberts, D. W., Lamphere, D. B., Grant, D. M., Grossman, S. J., and Spielberg, S. P. 1996. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem. Res. Toxicol. 9:500-507.
10. Firestone, G. L., Giampaolo, J. R., and O'Keeffe, B. A. 2003. Stimulus-dependent regulation of serum and glucocorticoid-inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol. Biochem. 13:1-12.
11. Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S., and Horii, A. 2003. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162:1807-1815.
12. Gautier, L., Cope, L., Bolstad, B. M., and Irizarry, R. A. 2004. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307-315.
13. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J. Y., and Zhang, J. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 5:R80.
14. Gong, P., and Cederbaum, A. J. 2006. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 43:144-153.
15. 1. J. Biol. Chem. 269:20707-20717.
16. Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M. Hobbs, B., and Speed, T. P. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
17. Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (Eds.) 2001. Immunobiology 5. New York: Garland Publishing-Taylor & Francis Group.
18. Jaruga, B., Hong, F., Kim, W. H., and Gao, B. 2004. IFN-γ /STAT1 acts as a pro-inflammatory signal in T-cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: A critical role of IRF-1. Am. J. Physiol. 287:G1044-G1052.
19. Ju, C., and Uetrecht, J. P. 2002. Mechanism of idiosyncratic drug reactions: Reactive metabolite formation, protein binding and the regulation of the immune system. Curr. Drug Metab. 3:367-377.
20. 1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 20:1215-1223.
21. Koenigs, L. L., Peter, R. M., Hunter, A. P., Haining, R. L., Rettie, A. E., Friedberg, T., Pritchard, M. P., Shou, M., Rushmore, T. H., and. Trager, W. F. 1999. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9. Biochemistry 38:2312-2319.
22. Landsteiner, K., and Jacobs, J. 1935. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 61:643-656.
23. Lopez-Flores, I., Barroso, J. B., Valderrama, R., Esteban, F. J., Martinez-Lara, E., Luque, F., Peinado, M. A., Ogawa, H., Lupianez, J. A., and Peragon. J. 2005. Serine dehydratase expression decreases in rat livers injured by chronic thioacetamide ingestion. Mol. Cell Biochem. 268:33-43.
24. Lopez-Garcia, M. P., Dansette, P. M., and Coloma, J. 2005. Kinetics of tienilic acid bioactivation and functional generation of drug-protein adducts in intact rat hepatocytes. Biochem. Pharmacol. 70:1870-1882.
25. Lopez-Garcia, M. P., Dansette, P. M., and Mansuy, D. 1994. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry 33:166-175.
26. Luisi, S., Florio, P., Reis, F. M., and Petraglia, F. 2001. Expression and secretion of activin A: Possible physiological and clinical implications. Eur. J. Endocrinol. 145:225-236.
27. Matzinger, P. 1994. Tolerance, danger and the extended family. Ann. Rev. Immunol. 12:991-1045.
28. Mishra, L., Cai, T., Yu, P., Monga, S. P., and Mishra, B. 1999. Elf3 encodes a novel 200-kD beta-spectrin: Role in liver development. Oncogene 18:353-364.
29. Mohn, K. L., Melby, A. E., Tewari, D. S., Laz, T. M., and Taub, R. 1991. The gene encoding rat insulin-like growth factor-binding protein 1 is rapidly and highly induced in regenerating liver. Mol. Cell Biol. 11:1393-1401.
30. Momoi, T. 2004. Caspases involved in ER stress-mediated cell death. J. Chem. Neuroanat. 28:101-105.
31. Nguyen, T., Yang, C. S., and Pickett, C. B. 2004. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Rad. Biol. Med. 37:433-441.
32. Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato, T., Yokochi-Fukuda, T., Waldmann, T. A., Taniguchi, T., and Taki, S. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700-703.
33. Pahl, H. L., and Baeuerle, P. A. 1997. The ER-overload response: Activation of NF-κB. Trends Biochem. Sci. 22:63-67.
34. Park, B. K., Kitteringham, N. R., Powell, H., and Pirmohamed, M. 2000. Advances in molecular toxicology - towards understanding idiosyncratic drug toxicity. Toxicology 153:39-60.
35. Robin, M. A., Maratrat, M., Le Roy, M., Le Breton, F. P., Bonierbale, E., Dansette, P., F. Ballet, E., Mansuy, D., and Pessayre, D. 1996. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J. Clin. Invest. 98:1471-1480.
36. Roujeau, J. C., and Stern, R. S. 1994. Severe adverse cutaneous reactions to drugs [see comments]. N. Engl. J. Med. 331:1272-1285.
37. Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M., Imura, N., and Hara, S. 2004. Over-expression of thioredoxin reductase 1 regulates NF-κB activation. J. Cell. Physiol. 198:22-30.
38. Seguin, B., and Uetrecht, J. 2003. The danger hypothesis applied to idiosyncratic drug reactions. Curr. Opin. Allergy Clin. Immunol. 3:235-242.
39. Stoeckert, C., Pizarro, A., Manduchi, E., Gibson, M., Brunk, B., Crabtree, J., Schug, J., Shen-Orr, S., and Overton, G. C. 2001. A relational scheme for both array-based and SAGE gene expression experiments. Bioinformatics 17:300-308.
40. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., and Biswal, S. 2002. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196-5203.
41. Thomas, R. S., Rank, D. R., Penn, S. G., Zastrow, G. M., Hayes, K. R., Pande, K., Glover, E., Silander, T., Craven, M. W., Reddy, J. K., Jovanovich, S. B., and Bradfield, C. A. 2001. Identification of toxicologically-predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60:1189-1194.
42. Turnley, A. M. 2005. Role of SOCS2 in growth hormone actions. Trends Endocrinol. Metab. 16:53-58.
43. Uetrecht, J. 2003. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. Drug Discov. Today 8:832-837.
44. Uetrecht, J. 2005. Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity. Toxicology 209:113-118.
45. Uetrecht, J. P. 2000. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? Curr. Drug Metab. 1:133-141.
46. Vance, R. E. 2000. Cutting edge: cutting edge commentary: A Copernican revolution? Doubts about the danger theory. J. Immunol. 165:1725-1728.
47. Wang, M. H., Zhou, Y. Q., and Chen, Y. Q. 2002. Macrophage-stimulating protein and RON receptor tyrosine kinase: Potential regulators of macrophage inflammatory activities. Scand. J. Immunol. 56:545-553.
48. Yang, C., Sun, M., Ilic, Z., Friedrich, T. D., and Sell, S. 2003. Reduced expression of p27kip1 and increased hepatocyte proliferation in p53-deficient mice. Mol. Carcinog. 36:15-22.
49. Zimmerman, H. (Ed.) 1999. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd Edition. Philadelphia: Lippincott Williams & Wilkins.